Browse Biotechnology industries topic

Health aspects subtopic

Articles 1-100 out of 100 article(s) Title Author Type Date Words Genzyme's Mozobil Shows Promise in Chemosensitization. Dec 8, 2009 1325 ImmunoCellular Therapeutics Enters into Option Agreement with The University of Texas M. D. Anderson Cancer Center for a Novel Cancer Stem Cell Therapy. Dec 2, 2009 638 Aduro Biotech Completes Series A-1 Financing. Nov 11, 2009 857 ImmunoCellular Therapeutics Presents Data from Phase I Trial of ICT-107 Demonstrating Significant Increase in Tumor-Free Progression in Patients with Brain Cancer. Oct 27, 2009 1127 United States : European panel reviewing infections linked to Tysabri. Oct 26, 2009 273 Updated Advaxis Phase I Survival Data Indicates Long-Term Immune Protection. Oct 1, 2009 671 Extending life and fighting disease with resveratrol. Goepp, Julius Report Aug 1, 2009 4921 Response Genetics to Present New Data at the 13th World Conference on Lung Cancer Supporting the Use of Gene Expression to Help Personalize Cancer Therapy Selection. Conference news Jul 31, 2009 1095 CytoDyn Completes Safety Testing of Cytolin[R]: Benchmark for Improved Treatment of HIV/AIDS. Jul 22, 2009 701 Compugen Announces Positive Therapeutic Effects of Novel Peptide in Animal Model of Retinopathy. Jul 21, 2009 1054 United Kingdom: Morphotek, Inc. and Cancer Innovations, Inc. Announce Evaluation and Option Agreement for Therapeutic Monoclonal Antibodies. Jul 16, 2009 429 Genzyme Reports Progress Related to Allston Plant. Jun 25, 2009 1522 Compugen Announces Additional Grants from Israel Office of Chief Scientist for Validation Studies of Therapeutic Candidates. Jun 24, 2009 607 Compugen Announces Positive Therapeutic Effects of Novel Peptide in Animal Model of Inflammatory Bowel Disease. Jun 23, 2009 1114 Seattle Genetics Initiates Phase II Trial of SGN-35 for Anaplastic Large Cell Lymphoma. Jun 18, 2009 862 Genentech Announces Full Results from First Phase III Study of Avastin in Early-Stage Colon Cancer. May 30, 2009 1676 Phase III Study Showed Patients Lived Longer Without Advanced Lung Cancer Progressing When Tarceva Was Added to Avastin as First-Line Maintenance Therapy. May 30, 2009 1744 Compugen Announces In Vivo Confirmation of Cardiovascular Therapeutic Potential for Two Novel Peptides. May 14, 2009 787 Advaxis' Phase 1 Clinical Cervix Cancer Study Accepted for Publication in Leading Peer-Reviewed Science Journal Vaccine. Apr 29, 2009 874 Avila Presents Preclinical Data on a Novel, Orally-Available, Protease Inhibitor, AVL181, for Hepatitis C Infection at EASL 2009 Meeting. Apr 27, 2009 844 Phase III C-08 Study of Avastin in Early-Stage Colon Cancer Did Not Meet Primary Endpoint. Report Apr 22, 2009 1125 Psoriasis drug may be linked to fatal infection. Feb 22, 2009 252 Research and Markets: Stem Cell-Based Therapeutic Delivery: Challenges & Opportunities. Feb 6, 2009 298 New Test Measures Cumulative Effects of Stress on the Body, Predicts Future Wellness or Illness. Dec 8, 2008 898 Hepatitis C Therapeutic DNA Vaccine Delivered by Inovio Biomedical's Electroporation Technology Reduces Viral Load by Up to 99.7%. Clinical report Nov 17, 2008 874 Avexa Presents Data from Apricitabine and Antibacterial Programs at two International Conferences. Conference news Nov 13, 2008 1005 IMM, Cenix, and Alnylam Discover New Targets in Malaria Infection with RNAi Technology. Nov 11, 2008 1415 Panacos Presents Phase 2b Bevirimat Data at the 48th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy. Conference news Oct 26, 2008 951 Abraxis BioScience and Specialised Therapeutics Australia Announce Approval to Market ABRAXANE for Metastatic Breast Cancer in Australia. Oct 16, 2008 1247 Genentech, GlycArt and Roche Enter into Collaboration Agreement for Potential Cancer Therapy. Oct 3, 2008 751 Morphotek(R), Inc. and Pivotal BioSciences Announce Agreement for the Development of Therapeutic Monoclonal Antibodies. Sep 25, 2008 558 BIO Announces Must-See Therapeutic Workshop Topics for Seventh Annual BIO Investor Forum. Sep 25, 2008 405 BIO Investor Advisory: BIO Announces Must-See Therapeutic Workshop Topics for Seventh Annual BIO Investor Forum. Sep 25, 2008 404 Nanobiotix and BiotechCorp Announce Initial Focus of Their Collaboration: P-O-C Diagnostics and Drug Delivery Systems for Tropical Diseases, Such as Malaria. Sep 24, 2008 588 United States: Transgenomic announces partnership with Key Genomics for ovarian cancer assay to guide therapeutic options. Sep 18, 2008 359 Instituto de Medicina Molecular, Cenix BioScience, and Alnylam Pharmaceuticals Discover New Pathway for Malaria Infection. Sep 11, 2008 1888 BioTime, Inc.'s Subsidiary, Embryome Sciences, Inc., Licenses Virus-Free iPS and Embryonic Stem Cell Differentiation Technology. Aug 21, 2008 1249 Advaxis Incorporated Receives List of Questions from the U.S. Food and Drug Administration. Jul 29, 2008 704 Compugen Announces Positive In-Vivo Results for Therapeutic Peptide Candidate for Immune Related Diseases. Financial report Jul 9, 2008 951 Introgen to Host Conference Call with Clinical Investigators to Discuss Phase III Data and ADVEXIN Registration Activities. Jul 8, 2008 589 Early Results from Ongoing Clinical Study of Hepatitis C Vaccine Delivered by Inovio Biomedical's Electroporation System Show Increased T-Cell Responses and Reduced Viral Loads. Jun 30, 2008 1010 Introgen Submits ADVEXIN(R) Regulatory Applications in the U.S. and Europe. Jun 30, 2008 1103 Case Western Reserve University School of Medicine with Copernicus Therapeutics and Polgenix Receive $3.9 Million from the Ohio Department of Development. Jun 30, 2008 939 MHC Biologics Sets Sights on the Next Generation of Monoclonal Antibody Therapies. Company overview Jun 16, 2008 700 Reduced Hepatitis C Viral Level Achieved with DNA Vaccine Delivered by Inovio Biomedical's Electroporation Delivery System in Phase I/II Clinical Study. Jun 4, 2008 813 Rosetta Genomics Announces Three New Diagnostic Tests to Enter Development New Development Programs to Include Response Prediction to Ovarian Cancer Treatment, Predicting Risk of Gastric Cancer Recurrence, and Differentiation of Small Cell From Non-Small Cell Lung Cancer. Jun 1, 2008 661 Response Genetics, Inc. to Announce Pancreatic, Colon and Gastric Cancer Results at the 2008 American Society of Clinical Oncology Annual Meeting. Clinical report May 29, 2008 999 Compugen Ltd. to Highlight Company's Therapeutic Discovery Platforms at BioMed Israel 2008. May 27, 2008 406 Quidel and Prodesse Announce Flu and RSV Molecular Partnership. May 20, 2008 1066 Hepatitis C Virus DNA Vaccine Shows Safety When Delivered by Inovio Biomedical's Electroporation Delivery System in Phase I/II Clinical Study at Karolinska University Hospital. Mar 17, 2008 1238 Bevirimat Data Presented at 15th Conference on Retroviruses and Opportunistic Infections. Conference news Feb 6, 2008 744 Partnering for Global Health Forum 2008 to Create a New Paradigm for Addressing Most Pressing Global Health Issues. Jan 24, 2008 480 Harmless Reovirus is a Cancer Killer. Jan 17, 2008 327 Saatchi & Saatchi Consumer Health+Wellness Wins Third New Business Pitch in Six Months. Jan 16, 2008 650 Nucleonics Initiates Hepatitis B Clinical Trial With Expressed Interfering RNA Therapeutic. Jan 11, 2008 683 Advanced Cell Technology Seeking International Partners for Its Therapeutic Programs. Dec 6, 2007 552 Can-Fite: IND submission for Phase I Clinical Trials with its Drug for Liver Diseases CF102. Dec 3, 2007 796 Inovio Biomedical Partner Tripep Treats First Subject in Phase I/II Study of Novel Hepatitis C DNA Vaccine. Nov 27, 2007 1468 Invitrogen and CytRx Subsidiary RXi Pharmaceuticals Collaborate to Enhance RNAi Technologies for Therapeutic Applications. Nov 14, 2007 918 Research and Markets: Lexicon Genetics Incorporated - Product Pipeline Report Provides Product Details with Description, Therapeutic Indication, Drug Class, Mechanism of Action, Current Trial, Trial Details and Partnering Details. Report Nov 9, 2007 240 ZYTO Corp. Announces Biotechnology Wellness Sales Tool for the Health Care and Wellness Industry. Nov 1, 2007 433 TransMolecular, Inc. Announces Formation of Medical Advisory Board. Oct 24, 2007 993 Advaxis Signs Agreement with Cobra For Manufacture of Lovaxin C Vaccine. Oct 18, 2007 714 Metabasis' liver cancer therapy granted orphan status abroad. Chambers, Heather Oct 15, 2007 227 Novel Antiviral HIV Drug SpirH(TM) Offers New Hope for AIDS Patients Worldwide. Oct 9, 2007 903 Morphotek Receives $2.7M in Funding from the National Institute of Allergy and Infectious Diseases to Develop Therapeutic Antibodies Against Biowarfare Agents. Oct 3, 2007 757 Introgen Announces Publication of Research Showing Promising Activity of INGN 241 Combined with Velcade(R) in Ovarian Cancer. Oct 2, 2007 714 Morphotek Receives $2.3M in Funding from the U.S. Department of Defense to Develop Therapeutic Antibodies Against Biowarfare Agents. Sep 19, 2007 645 Windhover Information Announces Its List of Top 10 Licensable Projects in the Hottest Therapeutic Areas. Sep 12, 2007 823 FDA Accepts Innovative Drug Application - ImmunoMod Begins Diabetes Therapeutic Trials. Jul 25, 2007 381 New Evidence on Calcifying Nanoparticle as a Cause of Chronic Infection, and Potential Danger of Other Nano-Apatite Particles Used in Medicine. Jun 28, 2007 348 Introgen and Clinical Collaborators to Report New Results with Advanced-Stage Cancer Therapies at Upcoming Medical Meetings. Clinical report May 29, 2007 844 Morphotek Signs Development and Clinical Supply Agreement with CMC Biopharmaceuticals A/S for Therapeutic Antibody to Treat Melanoma. May 21, 2007 524 Nucleonics Receives FDA Clearance to Begin Phase 1 Trial of Expressed RNAi Approach to Treating Chronic Hepatitis B Infections. May 2, 2007 443 Advaxis Completes Dosing and Enrollment of Third Cohort of Patients in Phase I/II Cervical Cancer Vaccine Trial. Apr 17, 2007 686 Illumina Technology Uncovers Genetic Risk Factors Associated with Prostate Cancer and Lou Gehrig's Disease. Apr 2, 2007 751 SATRAPLATIN REDUCES RISK OF PROSTATE CANCER PROGRESSION. Apr 1, 2007 1586 "NPR News Morning Edition" Runs Story on Allograft Safety, Includes Interview with Dr. Lennox Archibald. Mar 30, 2007 631 Biotechnology in Puerto Rico: Myths and hazards. Ruiz-Marrero, Carmelo Mar 22, 2007 2133 Avexa Reports Positive Phase IIb Result. Financial report Mar 20, 2007 1156 Recent HPV Findings by Centers for Disease Control and Prevention Validate Advaxis, Inc.'s Treatable Population. Mar 2, 2007 716 NYU partners with Rosetta to develop diagnostic tools for lung and mesothelioma cancers. Mar 1, 2007 617 Advanced Cell Technology Names Noted Biotech Industry Executive Dr. Pedro Huertas, as Chief Development Officer to Manage the Clinical Development and Regulatory Approval Process for its Stem Cell-Based Therapeutic Products. Feb 12, 2007 845 New Evidence on Infection as Chronic Disease Trigger Published, Debated by World-Class Scientists. Jan 31, 2007 587 Introgen Reports that INGN 241 in Combination with Avastin(R) Results in Complete Tumor Regression. Jan 24, 2007 789 Advanced Cell Technology Releases Corporate Video Presentation Highlighting Company's Pioneering Stem Cell Science and Therapeutic Development Programs. Jan 22, 2007 438 Advanced Cell Technology Announces Investor Conference Call to Be Held Friday January 19 to Discuss Key Events and Progress in Stem Cell-Based Therapeutic Programs. Jan 17, 2007 580 Seattle Genetics and Agensys Announce Collaboration to Co-Develop and Commercialize Antibody-Drug Conjugate Therapies for Cancer. Jan 8, 2007 955 Advaxis Partners with Gynecologic Oncology Group for Phase II Study of Company's Lead Cervical Cancer Vaccine. Dec 19, 2006 845 Companies Rely on RCT Protein Expression Technology to Make Therapeutic Products. Nov 27, 2006 454 RaySearch Laboratories: Nucletron and RaySearch Have Entered into a Development and License Agreement Regarding Treatment Planning for Proton Therapy in Cancer Treatment. Nov 16, 2006 677 Advaxis Completes Dosing and Enrollment of First Cohort of Patients in Phase I/II Cervical Cancer Vaccine Trial. Nov 7, 2006 659 Compugen Discloses Status of In Silico Discovered Therapeutic Candidates. Oct 19, 2006 1066 Alnylam Grants Quark a License to Develop and Commercialize Two RNAi Therapeutic Products. Sep 26, 2006 1662 Nextrials Enters into Agreement with ArQule to Replace Paper-Based Clinical Trial Data Collection and Management in Ongoing Cancer Therapy Study. Sep 18, 2006 444 Molecular biomarkers predicting efficacy of cancer therapy highlighted. Sep 1, 2006 538 Medinet and MaxCyte Initiate Collaboration for Novel Cancer Immuno-Cell Therapy. Aug 17, 2006 481 Interim Data on Use of tgAAC94 in the Treatment of Inflammatory Arthritis Presented at the European Rheumatology Meeting; Results Provide Preliminary Evidence for Sustained Improvement in Signs and Symptoms of Disease. Jun 22, 2006 1208 Compound Therapeutics Becomes Adnexus Therapeutics; Company Continues to Advance the AdNectin Therapeutic Class. Jun 21, 2006 468 First AdNectin Therapeutic, CT-322, Clears FDA IND Review to Start Clinical Trials; Anti-Cancer Therapeutic is a First in a Broadly Applicable, Innovative Class of Targeted Therapeutics. Jun 21, 2006 637